<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107487">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01786863</url>
  </required_header>
  <id_info>
    <org_study_id>IRB13-00045</org_study_id>
    <nct_id>NCT01786863</nct_id>
  </id_info>
  <brief_title>Frequency of Residual Neuromuscular Blockade in the Pediatric Population</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to investigate the frequency of Residual Neuromuscular Blockade
      (RNMB) in the pediatric population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study will be the first to investigate the incidence of residual postoperative
      neuromuscular blockade in the pediatric patient following the intraoperative use of NMBA's.
      If there is significant residual blockade present, it may be that these effects will lead to
      postoperative respiratory complications including hypoxemia, atelectasis, and prolonged
      oxygen requirement resulting in a prolonged stay in the post-anesthesia care unit.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>train-of-four (TOF) ratio</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>TOF ratio shows the residual of neuromuscular agents.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Surgery Requiring Paralysis.</condition>
  <arm_group>
    <arm_group_label>Neuromuscular blockade</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Neuromuscular blockade</intervention_name>
    <arm_group_label>Neuromuscular blockade</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing surgery that requires them to be paralyzed
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age less than 18 years.

          2. Surgery requiring the administration of neuromuscular blocking, agents with planned
             extubation in the postoperative care unit (PACU).

        Exclusion Criteria:

          1. Neuromuscular diseases which may prolong the duration of NMBA's or exaggerate the
             effects of residual blockade.

          2. The need for postoperative mechanical ventilation.

          3. Direct admission to the Pediatric ICU, NICU or CTICU.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nationwide Children's</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 8, 2013</lastchanged_date>
  <firstreceived_date>February 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Hiromi Kako</investigator_full_name>
    <investigator_title>Research Fellow</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
